Ann: PharmAust Forms World-Class Scientific Advisory Board, page-11

compounds that enhance autophagy have the potential to treat a wide range of neurodegenerative disease.

- MPL mechanism of action enhances autophagy.
- next week, we will know if this enhanced autophagy treats at least one neurodegenerative disease
- if yes, then the Professor says that it has the potential to treat a range of other neurodegenerative diseases.

That is, success next week, and value goes up by more that % success attributed to becoming SoC for MND/ALS ( 50% ? ).
You need to start throwing a % chance of success against other indications ( Alzheimer's Disease, Parkinson's etc. ), maybe 5%.

And that gets built into any offer for PAA.